PALLOTTA, DANTE PIO
PALLOTTA, DANTE PIO
Borsisti
Pure red cell aplasia due to Parvovirus B19 infection and atezolizumab: case report and literature review
2025 Pallotta, Dante Pio; Stefanini, Bernardo; Pratelli, Agnese; Papayannidis, Cristina; Bertuzzi, Clara; Boe, Maria; Girolami, Francesca; Tovoli, Francesco; Granito, Alessandro
TIMING THE SCAN: OPTIMIZING SCREENING FOR OSTEOPOROSIS AND RISK OF FRACTURE IN CELIAC DISEASE
2025 Tovoli, F.; Zavatta, G.; Monaco, G.; Pallotta, D. P.; Skoracka, K.; Raiteri, A.; Pratelli, A.; Boe, M.; Krela-Kazmierczak, I.; Pagotto, U.; Granito, A.
Intermediate-stage hepatocellular carcinoma: refining substaging or shifting paradigm?
2024 Stefanini, B.; Ielasi, L.; Pallotta, D. P.; Penazza, S.; Marseglia, M.; Piscaglia, F.
Suboptimal outcomes of sorafenib as a second-line treatment after atezolizumab-bevacizumab for unresectable hepatocellular carcinoma
2024 Tovoli, Francesco; Pallotta, Dante Pio; Vivaldi, Caterina; Campani, Claudia; Federico, Piera; Palloni, Andrea; Dalbeni, Andrea; Soldà, Caterina; Lani, Lorenzo; Svegliati-Baroni, Gianluca; Garajova, Ingrid; Ielasi, Luca; De Lorenzo, Stefania; Granito, Alessandro; Stefanini, Bernardo; Masi, Gianluca; Marra, Fabio; Lonardi, Sara; Brandi, Giovanni; Bruno, Daniele; Auriemma, Alessandra; Schiadà, Laura; Chen, Rusi; Piscaglia, Fabio
Evolution of bone densitometry parameters and risk of fracture in coeliac disease: a 10-year perspective
2023 Tovoli, Francesco; Pallotta, Dante Pio; Giamperoli, Alice; Zavatta, Guido; Skoracka, Kinga; Raiteri, Alberto; Faggiano, Chiara; Krela-Kaźmierczak, Iwona; Granito, Alessandro
Outcomes of Sorafenib for Recurrent Hepatocellular Carcinoma After Liver Transplantation in the Era of Combined and Sequential Treatments
2023 Tovoli, Francesco; Pallotta, Dante Pio; Sansone, Vito; Iavarone, Massimo; De Giorgio, Massimo; Ielasi, Luca; Di Costanzo, Giovan Giuseppe; Giuffrida, Paolo; Sacco, Rodolfo; Pressiani, Tiziana; Di Donato, Maria Francesca; Trevisani, Franco; Fagiuoli, Stefano; Piscaglia, Fabio; Granito, Alessandro
Risk of Drop-Out from Follow-Up Evaluations for Celiac Disease: Is It Similar for All Patients?
2022 Tovoli F.; Faggiano C.; Raiteri A.; Giamperoli A.; Catenaro T.; Sansone V.; Pallotta D.P.; Granito A.
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| Pure red cell aplasia due to Parvovirus B19 infection and atezolizumab: case report and literature review | Pallotta, Dante Pio; Stefanini, Bernardo; Pratelli, Agnese; Papayannidis, Cristina; Bertuzzi, Cla...ra; Boe, Maria; Girolami, Francesca; Tovoli, Francesco; Granito, Alessandro | 2025-01-01 | IMMUNOTHERAPY | - | 1.01 Articolo in rivista | - |
| TIMING THE SCAN: OPTIMIZING SCREENING FOR OSTEOPOROSIS AND RISK OF FRACTURE IN CELIAC DISEASE | Tovoli, F.; Zavatta, G.; Monaco, G.; Pallotta, D. P.; Skoracka, K.; Raiteri, A.; Pratelli, A.; Bo...e, M.; Krela-Kazmierczak, I.; Pagotto, U.; Granito, A. | 2025-01-01 | THE AMERICAN JOURNAL OF GASTROENTEROLOGY | - | 1.01 Articolo in rivista | - |
| Intermediate-stage hepatocellular carcinoma: refining substaging or shifting paradigm? | Stefanini, B.; Ielasi, L.; Pallotta, D. P.; Penazza, S.; Marseglia, M.; Piscaglia, F. | 2024-01-01 | JOURNAL OF LIVER CANCER | - | 1.01 Articolo in rivista | jlc-2024-02-21.pdf |
| Suboptimal outcomes of sorafenib as a second-line treatment after atezolizumab-bevacizumab for unresectable hepatocellular carcinoma | Tovoli, Francesco; Pallotta, Dante Pio; Vivaldi, Caterina; Campani, Claudia; Federico, Piera; Pal...loni, Andrea; Dalbeni, Andrea; Soldà, Caterina; Lani, Lorenzo; Svegliati-Baroni, Gianluca; Garajova, Ingrid; Ielasi, Luca; De Lorenzo, Stefania; Granito, Alessandro; Stefanini, Bernardo; Masi, Gianluca; Marra, Fabio; Lonardi, Sara; Brandi, Giovanni; Bruno, Daniele; Auriemma, Alessandra; Schiadà, Laura; Chen, Rusi; Piscaglia, Fabio | 2024-01-01 | DIGESTIVE AND LIVER DISEASE | - | 1.01 Articolo in rivista | PIIS1590865824009198.pdf; 1-s2.0-S1590865824009198-mmc1.docx |
| Evolution of bone densitometry parameters and risk of fracture in coeliac disease: a 10-year perspective | Tovoli, Francesco; Pallotta, Dante Pio; Giamperoli, Alice; Zavatta, Guido; Skoracka, Kinga; Raite...ri, Alberto; Faggiano, Chiara; Krela-Kaźmierczak, Iwona; Granito, Alessandro | 2023-01-01 | INTERNAL AND EMERGENCY MEDICINE | - | 1.01 Articolo in rivista | s11739-023-03307-7 (2).pdf; file supplementari.zip |
| Outcomes of Sorafenib for Recurrent Hepatocellular Carcinoma After Liver Transplantation in the Era of Combined and Sequential Treatments | Tovoli, Francesco; Pallotta, Dante Pio; Sansone, Vito; Iavarone, Massimo; De Giorgio, Massimo; Ie...lasi, Luca; Di Costanzo, Giovan Giuseppe; Giuffrida, Paolo; Sacco, Rodolfo; Pressiani, Tiziana; Di Donato, Maria Francesca; Trevisani, Franco; Fagiuoli, Stefano; Piscaglia, Fabio; Granito, Alessandro | 2023-01-01 | TRANSPLANTATION | - | 1.01 Articolo in rivista | SORAFENIB IN PATIENTS WITH RECURRENT HCC_R1.pdf |
| Risk of Drop-Out from Follow-Up Evaluations for Celiac Disease: Is It Similar for All Patients? | Tovoli F.; Faggiano C.; Raiteri A.; Giamperoli A.; Catenaro T.; Sansone V.; Pallotta D.P.; Granit...o A. | 2022-01-01 | NUTRIENTS | - | 1.01 Articolo in rivista | 87. celiac dropout.pdf |